Last 12 months
Inside the activity.
12 purchase rows · 16 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 8 | 2 |
| Dec 2025 | 4 | 0 |
| Jan 2026 | 0 | 1 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 3 |
| Jun 2026 | 0 | 4 |
| Jul 2026 | 0 | 2 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 4 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 15, 2026 Filed Mar 17, 2026 20:59 UTC |
Tachibana AaronCFO AND COO
|
GrantCommon Stock | 34,375 | $0.00 | $0.00 |
DisclosureSEC source: 0001401786-26-000003 · form4-03172026_080312.xml · nonDerivative · entry 1 Tachibana Aaron · CIK 0001401786 · CFO AND COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 198,833 F1 · shares: Each share is represented by a restricted stock unit ("RSU"). Each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement. The RSUs vest in 6 equal semi-annual installments with the first installment vesting on September 15, 2026. Read SEC document |
| March 15, 2026 Filed Mar 17, 2026 20:54 UTC |
Chen RichardPresident and CMO
|
GrantStock Option (right to buy) · Derivative | 281,250 | $0.00 Strike: $6.72 | $0.00 |
DisclosureSEC source: 0001779787-26-000002 · form4-03172026_080357.xml · derivative · entry 2 Chen Richard · CIK 0001779787 · President and CMO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 281,250 Underlying: Common Stock · 281,250 shares Expires 2036-03-15 F3 · derivative.exercise_date: The shares subject to the option vest in 36 equal monthly installments with the first installment vesting on April 15, 2026. Read SEC document |
| March 15, 2026 Filed Mar 17, 2026 20:54 UTC |
Chen RichardPresident and CMO
|
GrantCommon Stock | 46,875 | $0.00 | $0.00 |
DisclosureSEC source: 0001779787-26-000002 · form4-03172026_080357.xml · nonDerivative · entry 1 Chen Richard · CIK 0001779787 · President and CMO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 173,880 F1 · shares: Each share is represented by a restricted stock unit ("RSU"). Each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement. The RSUs vest in 6 equal semi-annual installments with the first installment vesting on September 15, 2026. F2 · balance_after: Includes 2,500 shares acquired under the Issuer's Employee Stock Purchase Plan on October 31, 2025. Read SEC document |
| March 15, 2026 Filed Mar 17, 2026 20:57 UTC |
Moore Stephen MichaelSVP and Chief Legal Officer
|
GrantStock Option (right to buy) · Derivative | 168,750 | $0.00 Strike: $6.72 | $0.00 |
DisclosureSEC source: 0001915342-26-000002 · form4-03172026_080346.xml · derivative · entry 2 Moore Stephen Michael · CIK 0001915342 · SVP and Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 168,750 Underlying: Common Stock · 168,750 shares Expires 2036-03-15 F2 · derivative.exercise_date: The shares subject to the option vest in 36 equal monthly installments with the first installment vesting on April 15, 2026. Read SEC document |
| March 15, 2026 Filed Mar 17, 2026 20:57 UTC |
Moore Stephen MichaelSVP and Chief Legal Officer
|
GrantCommon Stock | 28,125 | $0.00 | $0.00 |
DisclosureSEC source: 0001915342-26-000002 · form4-03172026_080346.xml · nonDerivative · entry 1 Moore Stephen Michael · CIK 0001915342 · SVP and Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 92,325 F1 · shares: Each share is represented by a restricted stock unit ("RSU"). Each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement. The RSUs vest in 6 equal semi-annual installments with the first installment vesting on September 15, 2026. Read SEC document |
| February 23, 2026 Filed Feb 25, 2026 23:47 UTC |
Hall Christopher MDirector · PRESIDENT AND CEO
|
GrantStock Option (right to buy) · Derivative | 33,333 | $0.00 Strike: $1.61 | $0.00 |
DisclosureSEC source: 0001449535-26-000001 · form4-02252026_110220.xml · derivative · entry 1 Hall Christopher M · CIK 0001449535 · Director · PRESIDENT AND CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,333 Underlying: Common Stock · 33,333 shares Expires 2034-03-15 F1 · balance_after: This amount represents the vesting of a performance stock option granted on March 15, 2024, following the satisfaction of a specified reimbursement milestone. Read SEC document |
| February 23, 2026 Filed Feb 25, 2026 23:51 UTC |
Tachibana AaronCFO AND COO
|
GrantStock Option (right to buy) · Derivative | 15,000 | $0.00 Strike: $1.61 | $0.00 |
DisclosureSEC source: 0001401786-26-000002 · form4-02252026_110223.xml · derivative · entry 1 Tachibana Aaron · CIK 0001401786 · CFO AND COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2034-03-15 F1 · balance_after: This amount represents the vesting of a performance stock option granted on March 15, 2024, following the satisfaction of a specified reimbursement milestone. Read SEC document |
| February 23, 2026 Filed Feb 25, 2026 23:50 UTC |
Chen RichardCHIEF MEDICAL OFFICER AND EVP
|
GrantStock Option (right to buy) · Derivative | 15,000 | $0.00 Strike: $1.61 | $0.00 |
DisclosureSEC source: 0001779787-26-000001 · form4-02252026_110211.xml · derivative · entry 1 Chen Richard · CIK 0001779787 · CHIEF MEDICAL OFFICER AND EVP 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2034-03-15 F1 · balance_after: This amount represents the vesting of a performance stock option granted on March 15, 2024, following the satisfaction of a specified reimbursement milestone. Read SEC document |
| February 23, 2026 Filed Feb 25, 2026 23:48 UTC |
Moore Stephen MichaelSVP and Chief Legal Officer
|
GrantStock Option (right to buy) · Derivative | 8,333 | $0.00 Strike: $1.61 | $0.00 |
DisclosureSEC source: 0001915342-26-000001 · form4-02252026_110252.xml · derivative · entry 1 Moore Stephen Michael · CIK 0001915342 · SVP and Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,333 Underlying: Common Stock · 8,333 shares Expires 2034-03-15 F1 · balance_after: This amount represents the vesting of a performance stock option granted on March 15, 2024, following the satisfaction of a specified reimbursement milestone. Read SEC document |
| January 22, 2026 Filed Jan 23, 2026 23:03 UTC |
Tachibana AaronCFO AND COO
|
Exercise / conversionStock Option (right to buy) · Derivative | 1,201 | $0.00 Strike: $9.16 | $0.00 |
DisclosureSEC source: 0001401786-26-000001 · form4-01232026_110156.xml · derivative · entry 3 Tachibana Aaron · CIK 0001401786 · CFO AND COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 107,631 Underlying: Common Stock · 1,201 shares Expires 2029-03-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales and option exercise reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 7, 2025. F2 · derivative.exercise_date: The shares subject to the option are fully vested and exercisable. Read SEC document |
| January 22, 2026 Filed Jan 23, 2026 23:03 UTC |
Tachibana AaronCFO AND COO
|
SaleCommon Stock | 1,201 | $11.50 | $13,811.50 |
DisclosureSEC source: 0001401786-26-000001 · form4-01232026_110156.xml · nonDerivative · entry 2 Tachibana Aaron · CIK 0001401786 · CFO AND COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 164,458 F1 · kind: The sales and option exercise reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 7, 2025. Read SEC document |
| January 22, 2026 Filed Jan 23, 2026 23:03 UTC |
Tachibana AaronCFO AND COO
|
Exercise / conversionCommon Stock | 1,201 | $9.16 | $11,001.16 |
DisclosureSEC source: 0001401786-26-000001 · form4-01232026_110156.xml · nonDerivative · entry 1 Tachibana Aaron · CIK 0001401786 · CFO AND COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 165,659 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales and option exercise reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 7, 2025. Read SEC document |
| December 22, 2025 Filed Feb 13, 2026 22:24 UTC |
Tempus AI, Inc.10% owner
|
PurchaseCommon Stock | 28,000 | $8.93 | $250,040.00 |
DisclosureSEC source: 0001193125-26-051798 · ownership.xml · nonDerivative · entry 12 Tempus AI, Inc. · CIK 0001717115 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,039,067 F12 · shares: This price reflects the weighted average price at which these shares were purchased. The shares were purchased in multiple transactions at prices ranging from $8.73 to $9.08, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. F12 · price: This price reflects the weighted average price at which these shares were purchased. The shares were purchased in multiple transactions at prices ranging from $8.73 to $9.08, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| December 19, 2025 Filed Feb 13, 2026 22:24 UTC |
Tempus AI, Inc.10% owner
|
PurchaseCommon Stock | 29,641 | $8.39 | $248,687.99 |
DisclosureSEC source: 0001193125-26-051798 · ownership.xml · nonDerivative · entry 11 Tempus AI, Inc. · CIK 0001717115 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,011,067 F11 · shares: This price reflects the weighted average price at which these shares were purchased. The shares were purchased in multiple transactions at prices ranging from $8.09 to $8.63, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. F11 · price: This price reflects the weighted average price at which these shares were purchased. The shares were purchased in multiple transactions at prices ranging from $8.09 to $8.63, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| December 18, 2025 Filed Feb 13, 2026 22:24 UTC |
Tempus AI, Inc.10% owner
|
PurchaseCommon Stock | 31,430 | $7.91 | $248,611.30 |
DisclosureSEC source: 0001193125-26-051798 · ownership.xml · nonDerivative · entry 10 Tempus AI, Inc. · CIK 0001717115 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,981,426 F10 · shares: This price reflects the weighted average price at which these shares were purchased. The shares were purchased in multiple transactions at prices ranging from $7.80 to $8.38, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. F10 · price: This price reflects the weighted average price at which these shares were purchased. The shares were purchased in multiple transactions at prices ranging from $7.80 to $8.38, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| December 17, 2025 Filed Feb 13, 2026 22:24 UTC |
Tempus AI, Inc.10% owner
|
PurchaseCommon Stock | 31,650 | $7.86 | $248,769.00 |
DisclosureSEC source: 0001193125-26-051798 · ownership.xml · nonDerivative · entry 9 Tempus AI, Inc. · CIK 0001717115 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,949,996 F9 · shares: This price reflects the weighted average price at which these shares were purchased. The shares were purchased in multiple transactions at prices ranging from $7.75 to $7.93, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. F9 · price: This price reflects the weighted average price at which these shares were purchased. The shares were purchased in multiple transactions at prices ranging from $7.75 to $7.93, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| November 25, 2025 Filed Nov 28, 2025 22:09 UTC |
Tachibana AaronCFO AND COO
|
Exercise / conversionStock Option (right to buy) · Derivative | 103,668 | $0.00 Strike: $9.16 | $0.00 |
DisclosureSEC source: 0001401786-25-000004 · form4-11282025_101141.xml · derivative · entry 3 Tachibana Aaron · CIK 0001401786 · CFO AND COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 108,832 Underlying: Common Stock · 103,668 shares Expires 2029-03-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales and option exercise reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 7, 2025. F3 · derivative.exercise_date: The shares subject to the option are fully vested and exercisable. Read SEC document |
| November 25, 2025 Filed Nov 28, 2025 22:09 UTC |
Tachibana AaronCFO AND COO
|
SaleCommon Stock | 103,668 | $10.78 | $1,117,541.04 |
DisclosureSEC source: 0001401786-25-000004 · form4-11282025_101141.xml · nonDerivative · entry 2 Tachibana Aaron · CIK 0001401786 · CFO AND COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 164,458 F1 · kind: The sales and option exercise reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 7, 2025. F2 · price: The price reported above reflects the weighted average price of the shares sold. The sale price ranged from $10.25 to $11.10 per share. Upon request from the SEC staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| November 25, 2025 Filed Nov 28, 2025 22:09 UTC |
Tachibana AaronCFO AND COO
|
Exercise / conversionCommon Stock | 103,668 | $9.16 | $949,598.88 |
DisclosureSEC source: 0001401786-25-000004 · form4-11282025_101141.xml · nonDerivative · entry 1 Tachibana Aaron · CIK 0001401786 · CFO AND COO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 268,126 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales and option exercise reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 7, 2025. Read SEC document |
| November 25, 2025 Filed Feb 13, 2026 22:24 UTC |
Tempus AI, Inc.10% owner
|
PurchaseCommon Stock | 13,888 | $11.00 | $152,768.00 |
DisclosureSEC source: 0001193125-26-051798 · ownership.xml · nonDerivative · entry 8 Tempus AI, Inc. · CIK 0001717115 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,918,346 F8 · shares: This price reflects the weighted average price at which these shares were purchased. The shares were purchased in multiple transactions at prices ranging from $10.47 to $11.23, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. F8 · price: This price reflects the weighted average price at which these shares were purchased. The shares were purchased in multiple transactions at prices ranging from $10.47 to $11.23, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| November 25, 2025 Filed Feb 13, 2026 22:24 UTC |
Tempus AI, Inc.10% owner
|
PurchaseCommon Stock | 9,712 | $10.08 | $97,896.96 |
DisclosureSEC source: 0001193125-26-051798 · ownership.xml · nonDerivative · entry 7 Tempus AI, Inc. · CIK 0001717115 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,904,458 F7 · shares: This price reflects the weighted average price at which these shares were purchased. The shares were purchased in multiple transactions at prices ranging from $9.47 to $10.46, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. F7 · price: This price reflects the weighted average price at which these shares were purchased. The shares were purchased in multiple transactions at prices ranging from $9.47 to $10.46, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| November 24, 2025 Filed Feb 13, 2026 22:24 UTC |
Tempus AI, Inc.10% owner
|
PurchaseCommon Stock | 25,225 | $9.87 | $248,970.75 |
DisclosureSEC source: 0001193125-26-051798 · ownership.xml · nonDerivative · entry 6 Tempus AI, Inc. · CIK 0001717115 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,894,746 F6 · shares: This price reflects the weighted average price at which these shares were purchased. The shares were purchased in multiple transactions at prices ranging from $9.69 to $10.12, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. F6 · price: This price reflects the weighted average price at which these shares were purchased. The shares were purchased in multiple transactions at prices ranging from $9.69 to $10.12, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| November 21, 2025 Filed Feb 13, 2026 22:24 UTC |
Tempus AI, Inc.10% owner
|
PurchaseCommon Stock | 16,599 | $9.74 | $161,674.26 |
DisclosureSEC source: 0001193125-26-051798 · ownership.xml · nonDerivative · entry 5 Tempus AI, Inc. · CIK 0001717115 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,869,521 F5 · shares: This price reflects the weighted average price at which these shares were purchased. The shares were purchased in multiple transactions at prices ranging from $9.48 to $9.85, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. F5 · price: This price reflects the weighted average price at which these shares were purchased. The shares were purchased in multiple transactions at prices ranging from $9.48 to $9.85, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| November 21, 2025 Filed Feb 13, 2026 22:24 UTC |
Tempus AI, Inc.10% owner
|
PurchaseCommon Stock | 9,900 | $8.84 | $87,516.00 |
DisclosureSEC source: 0001193125-26-051798 · ownership.xml · nonDerivative · entry 4 Tempus AI, Inc. · CIK 0001717115 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,852,922 F4 · shares: This price reflects the weighted average price at which these shares were purchased. The shares were purchased in multiple transactions at prices ranging from $8.40 to $9.40, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. F4 · price: This price reflects the weighted average price at which these shares were purchased. The shares were purchased in multiple transactions at prices ranging from $8.40 to $9.40, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| November 20, 2025 Filed Feb 13, 2026 22:24 UTC |
Tempus AI, Inc.10% owner
|
PurchaseCommon Stock | 28,827 | $8.63 | $248,777.01 |
DisclosureSEC source: 0001193125-26-051798 · ownership.xml · nonDerivative · entry 3 Tempus AI, Inc. · CIK 0001717115 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,843,022 F3 · shares: This price reflects the weighted average price at which these shares were purchased. The shares were purchased in multiple transactions at prices ranging from $8.28 to $9.10, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. F3 · price: This price reflects the weighted average price at which these shares were purchased. The shares were purchased in multiple transactions at prices ranging from $8.28 to $9.10, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| November 19, 2025 Filed Feb 13, 2026 22:24 UTC |
Tempus AI, Inc.10% owner
|
PurchaseCommon Stock | 30,645 | $8.12 | $248,837.40 |
DisclosureSEC source: 0001193125-26-051798 · ownership.xml · nonDerivative · entry 2 Tempus AI, Inc. · CIK 0001717115 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,814,195 F2 · shares: This price reflects the weighted average price at which these shares were purchased. The shares were purchased in multiple transactions at prices ranging from $7.80 to $8.40, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. F2 · price: This price reflects the weighted average price at which these shares were purchased. The shares were purchased in multiple transactions at prices ranging from $7.80 to $8.40, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| November 18, 2025 Filed Feb 13, 2026 22:24 UTC |
Tempus AI, Inc.10% owner
|
PurchaseCommon Stock | 64,750 | $7.67 | $496,632.50 |
DisclosureSEC source: 0001193125-26-051798 · ownership.xml · nonDerivative · entry 1 Tempus AI, Inc. · CIK 0001717115 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,783,550 F1 · shares: This price reflects the weighted average price at which these shares were purchased. The shares were purchased in multiple transactions at prices ranging from $7.36 to $7.88, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. F1 · price: This price reflects the weighted average price at which these shares were purchased. The shares were purchased in multiple transactions at prices ranging from $7.36 to $7.88, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| November 03, 2025 Filed Nov 5, 2025 21:05 UTC |
Hall Christopher MDirector · PRESIDENT AND CEO
|
SaleCommon Stock | 29,612 | $8.99 | $266,211.88 |
DisclosureSEC source: 0001449535-25-000004 · form4-11052025_041103.xml · nonDerivative · entry 1 Hall Christopher M · CIK 0001449535 · Director · PRESIDENT AND CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 148,486 F1 · shares: Shares automatically sold to cover tax withholding obligation from settlement of vested restricted stock units. F2 · price: The price reported above reflects the weighted average price of the shares sold. The sale price ranged from $8.78 to $9.56 per share. Upon request from the SEC staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| July 28, 2025 Filed Jul 30, 2025 20:20 UTC |
Tachibana AaronCFO AND COO
|
SaleCommon Stock | 641 | $6.57 | $4,211.37 |
DisclosureSEC source: 0001415889-25-020571 · form4-07302025_040701.xml · nonDerivative · entry 1 Tachibana Aaron · CIK 0001401786 · CFO AND COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 164,458 F1 · shares: Shares automatically sold to cover tax withholding obligation from settlement of vested restricted stock units. Read SEC document |
| July 28, 2025 Filed Jul 30, 2025 20:20 UTC |
Chen RichardCHIEF MEDICAL OFFICER AND EVP
|
SaleCommon Stock | 452 | $6.57 | $2,969.64 |
DisclosureSEC source: 0001415889-25-020572 · form4-07302025_040703.xml · nonDerivative · entry 1 Chen Richard · CIK 0001779787 · CHIEF MEDICAL OFFICER AND EVP 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 124,505 F1 · shares: Shares automatically sold to cover tax withholding obligation from settlement of vested restricted stock units. Read SEC document |
| May 16, 2025 Filed May 20, 2025 20:13 UTC |
BOWMAN A BLAINEDirector
|
GrantStock Option (right to buy) · Derivative | 50,000 | $0.00 Strike: $4.95 | $0.00 |
DisclosureSEC source: 0001415889-25-013794 · form4-05202025_080543.xml · derivative · entry 1 BOWMAN A BLAINE · CIK 0001008891 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2035-05-16 F1 · derivative.exercise_date: 100% of the shares subject to the option shall vest on the earlier of the one-year anniversary of the grant date or the day prior to the Company's next annual meeting of stockholders occurring after the grant date, subject to the reporting person's Continuous Service (as defined in the Company's 2019 Equity Incentive Plan) through the vesting date. In the event of a Change in Control (as defined in the Company's 2019 Equity Incentive Plan), the shares underlying the option shall vest and become exercisable immediately prior to the effectiveness of such Change in Control. Read SEC document |
| May 16, 2025 Filed May 20, 2025 20:15 UTC |
WIDDER KENNETH JDirector
|
GrantStock Option (right to buy) · Derivative | 50,000 | $0.00 Strike: $4.95 | $0.00 |
DisclosureSEC source: 0001415889-25-013799 · form4-05202025_080544.xml · derivative · entry 1 WIDDER KENNETH J · CIK 0001065168 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2035-05-16 F1 · derivative.exercise_date: 100% of the shares subject to the option shall vest on the earlier of the one-year anniversary of the grant date or the day prior to the Company's next annual meeting of stockholders occurring after the grant date, subject to the reporting person's Continuous Service (as defined in the Company's 2019 Equity Incentive Plan) through the vesting date. In the event of a Change in Control (as defined in the Company's 2019 Equity Incentive Plan), the shares underlying the option shall vest and become exercisable immediately prior to the effectiveness of such Change in Control. Read SEC document |
| May 16, 2025 Filed May 20, 2025 20:16 UTC |
Shoff LonnieDirector
|
GrantStock Option (right to buy) · Derivative | 50,000 | $0.00 Strike: $4.95 | $0.00 |
DisclosureSEC source: 0001415889-25-013800 · form4-05202025_080550.xml · derivative · entry 1 Shoff Lonnie · CIK 0001471716 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2035-05-16 F1 · derivative.exercise_date: 100% of the shares subject to the option shall vest on the earlier of the one-year anniversary of the grant date or the day prior to the Company's next annual meeting of stockholders occurring after the grant date, subject to the reporting person's Continuous Service (as defined in the Company's 2019 Equity Incentive Plan) through the vesting date. In the event of a Change in Control (as defined in the Company's 2019 Equity Incentive Plan), the shares underlying the option shall vest and become exercisable immediately prior to the effectiveness of such Change in Control. Read SEC document |
| May 16, 2025 Filed May 20, 2025 21:53 UTC |
Tachibana AaronCFO AND COO
|
SaleCommon Stock | 1,291 | $4.95 | $6,390.45 |
DisclosureSEC source: 0001415889-25-013848 · form4-05202025_090507.xml · nonDerivative · entry 1 Tachibana Aaron · CIK 0001401786 · CFO AND COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 165,099 F1 · shares: Shares automatically sold to cover tax withholding obligation from settlement of vested restricted stock units. F2 · price: The price reported above reflects the weighted average price of the shares sold. The sale price ranged from $4.85 to $5.05 per share. Upon request from the SEC staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| May 16, 2025 Filed May 20, 2025 20:12 UTC |
MYERS WOODROW A JRDirector
|
GrantStock Option (right to buy) · Derivative | 50,000 | $0.00 Strike: $4.95 | $0.00 |
DisclosureSEC source: 0001415889-25-013791 · form4-05202025_080503.xml · derivative · entry 1 MYERS WOODROW A JR · CIK 0001243399 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2035-05-16 F1 · derivative.exercise_date: 100% of the shares subject to the option shall vest on the earlier of the one-year anniversary of the grant date or the day prior to the Company's next annual meeting of stockholders occurring after the grant date, subject to the reporting person's Continuous Service (as defined in the Company's 2019 Equity Incentive Plan) through the vesting date. In the event of a Change in Control (as defined in the Company's 2019 Equity Incentive Plan), the shares underlying the option shall vest and become exercisable immediately prior to the effectiveness of such Change in Control. Read SEC document |
| May 16, 2025 Filed May 20, 2025 20:14 UTC |
EASTHAM KARINDirector
|
GrantStock Option (right to buy) · Derivative | 50,000 | $0.00 Strike: $4.95 | $0.00 |
DisclosureSEC source: 0001415889-25-013797 · form4-05202025_080545.xml · derivative · entry 1 EASTHAM KARIN · CIK 0001231845 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2035-05-16 F1 · derivative.exercise_date: 100% of the shares subject to the option shall vest on the earlier of the one-year anniversary of the grant date or the day prior to the Company's next annual meeting of stockholders occurring after the grant date, subject to the reporting person's Continuous Service (as defined in the Company's 2019 Equity Incentive Plan) through the vesting date. In the event of a Change in Control (as defined in the Company's 2019 Equity Incentive Plan), the shares underlying the option shall vest and become exercisable immediately prior to the effectiveness of such Change in Control. Read SEC document |
| May 16, 2025 Filed May 20, 2025 20:18 UTC |
Bloom Olivia KyusukDirector
|
GrantStock Option (right to buy) · Derivative | 50,000 | $0.00 Strike: $4.95 | $0.00 |
DisclosureSEC source: 0001415889-25-013801 · form4-05202025_080517.xml · derivative · entry 1 Bloom Olivia Kyusuk · CIK 0001501545 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2035-05-16 F1 · derivative.exercise_date: 100% of the shares subject to the option shall vest on the earlier of the one-year anniversary of the grant date or the day prior to the Company's next annual meeting of stockholders occurring after the grant date, subject to the reporting person's Continuous Service (as defined in the Company's 2019 Equity Incentive Plan) through the vesting date. In the event of a Change in Control (as defined in the Company's 2019 Equity Incentive Plan), the shares underlying the option shall vest and become exercisable immediately prior to the effectiveness of such Change in Control. Read SEC document |
| May 16, 2025 Filed May 20, 2025 21:51 UTC |
Moore Stephen MichaelSVP and Chief Legal Officer
|
SaleCommon Stock | 1,675 | $4.95 | $8,291.25 |
DisclosureSEC source: 0001415889-25-013847 · form4-05202025_090547.xml · nonDerivative · entry 1 Moore Stephen Michael · CIK 0001915342 · SVP and Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 64,200 F1 · shares: Shares automatically sold to cover tax withholding obligation from settlement of vested restricted stock units. F2 · price: The price reported above reflects the weighted average price of the shares sold. The sale price ranged from $4.85 to $5.05 per share. Upon request from the SEC staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| May 16, 2025 Filed May 20, 2025 21:50 UTC |
Chen RichardCHIEF MEDICAL OFFICER AND EVP
|
SaleCommon Stock | 910 | $4.95 | $4,504.50 |
DisclosureSEC source: 0001415889-25-013846 · form4-05202025_090557.xml · nonDerivative · entry 1 Chen Richard · CIK 0001779787 · CHIEF MEDICAL OFFICER AND EVP 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 124,957 F1 · shares: Shares automatically sold to cover tax withholding obligation from settlement of vested restricted stock units. F2 · price: The price reported above reflects the weighted average price of the shares sold. The sale price ranged from $4.85 to $5.05 per share. Upon request from the SEC staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. F3 · balance_after: Includes 2,500 shares acquired under the Issuer's Employee Stock Purchase Plan on April 30, 2025. Read SEC document |
| March 15, 2025 Filed Mar 18, 2025 20:44 UTC |
Hall Christopher MDirector · PRESIDENT AND CEO
|
GrantStock Option (right to buy) · Derivative | 680,000 | $0.00 Strike: $3.63 | $0.00 |
DisclosureSEC source: 0001415889-25-008427 · form4-03182025_080340.xml · derivative · entry 1 Hall Christopher M · CIK 0001449535 · Director · PRESIDENT AND CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 680,000 Underlying: Common Stock · 680,000 shares Expires 2035-03-15 F1 · derivative.exercise_date: The shares subject to the option vest in 36 equal monthly installments with the first installment vesting on April 15, 2025. Read SEC document |
| March 15, 2025 Filed Mar 18, 2025 20:50 UTC |
Tachibana AaronCFO AND COO
|
GrantStock Option (right to buy) · Derivative | 250,000 | $0.00 Strike: $3.63 | $0.00 |
DisclosureSEC source: 0001415889-25-008434 · form4-03182025_080309.xml · derivative · entry 1 Tachibana Aaron · CIK 0001401786 · CFO AND COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 250,000 Underlying: Common Stock · 250,000 shares Expires 2035-03-15 F1 · derivative.exercise_date: The shares subject to the option vest in 36 equal monthly installments with the first installment vesting on April 15, 2025. Read SEC document |
| March 15, 2025 Filed Mar 18, 2025 20:46 UTC |
Moore Stephen MichaelSVP and Chief Legal Officer
|
GrantStock Option (right to buy) · Derivative | 225,000 | $0.00 Strike: $3.63 | $0.00 |
DisclosureSEC source: 0001415889-25-008431 · form4-03182025_080345.xml · derivative · entry 1 Moore Stephen Michael · CIK 0001915342 · SVP and Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 225,000 Underlying: Common Stock · 225,000 shares Expires 2035-03-15 F1 · derivative.exercise_date: The shares subject to the option vest in 36 equal monthly installments with the first installment vesting on April 15, 2025. Read SEC document |
| March 15, 2025 Filed Mar 18, 2025 20:41 UTC |
Chen RichardCHIEF MEDICAL OFFICER AND EVP
|
GrantStock Option (right to buy) · Derivative | 250,000 | $0.00 Strike: $3.63 | $0.00 |
DisclosureSEC source: 0001415889-25-008415 · form4-03182025_080321.xml · derivative · entry 1 Chen Richard · CIK 0001779787 · CHIEF MEDICAL OFFICER AND EVP 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 250,000 Underlying: Common Stock · 250,000 shares Expires 2035-03-15 F1 · derivative.exercise_date: The shares subject to the option vest in 36 equal monthly installments with the first installment vesting on April 15, 2025. Read SEC document |
| January 28, 2025 Filed Jan 30, 2025 22:01 UTC |
Tachibana AaronCFO AND COO
|
SaleCommon Stock | 708 | $5.79 | $4,099.32 |
DisclosureSEC source: 0001415889-25-002398 · form4-01302025_100132.xml · nonDerivative · entry 1 Tachibana Aaron · CIK 0001401786 · CFO AND COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 166,390 F1 · shares: Shares automatically sold to cover tax withholding obligation from settlement of vested restricted stock units. Read SEC document |
| January 28, 2025 Filed Jan 30, 2025 21:59 UTC |
Chen RichardCHIEF MEDICAL OFFICER AND EVP
|
SaleCommon Stock | 519 | $5.79 | $3,005.01 |
DisclosureSEC source: 0001415889-25-002386 · form4-01302025_090150.xml · nonDerivative · entry 1 Chen Richard · CIK 0001779787 · CHIEF MEDICAL OFFICER AND EVP 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 123,367 F1 · shares: Shares automatically sold to cover tax withholding obligation from settlement of vested restricted stock units. Read SEC document |
| December 16, 2024 Filed Dec 18, 2024 21:25 UTC |
Tachibana AaronCFO AND COO
|
SaleCommon Stock | 6,865 | $3.82 | $26,224.30 |
DisclosureSEC source: 0001415889-24-029736 · form4-12182024_041201.xml · nonDerivative · entry 1 Tachibana Aaron · CIK 0001401786 · CFO AND COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 167,098 F1 · shares: Shares automatically sold to cover tax withholding obligation from settlement of vested restricted stock units. F2 · price: The price reported above reflects the weighted average price of the shares sold. The sale price ranged from $3.65 to $3.91 per share. Upon request from the SEC staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| December 16, 2024 Filed Dec 18, 2024 21:35 UTC |
Chen RichardCHIEF MEDICAL OFFICER AND EVP
|
SaleCommon Stock | 4,834 | $3.82 | $18,465.88 |
DisclosureSEC source: 0001415889-24-029741 · form4-12182024_041201.xml · nonDerivative · entry 1 Chen Richard · CIK 0001779787 · CHIEF MEDICAL OFFICER AND EVP 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 123,886 F1 · shares: Shares automatically sold to cover tax withholding obligation from settlement of vested restricted stock units. F2 · price: The price reported above reflects the weighted average price of the shares sold. The sale price ranged from $3.65 to $3.91 per share. Upon request from the SEC staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| December 16, 2024 Filed Dec 18, 2024 21:30 UTC |
Moore Stephen MichaelSVP and Chief Legal Officer
|
SaleCommon Stock | 1,513 | $3.82 | $5,779.66 |
DisclosureSEC source: 0001415889-24-029739 · form4-12182024_041203.xml · nonDerivative · entry 1 Moore Stephen Michael · CIK 0001915342 · SVP and Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 65,875 F1 · shares: Shares automatically sold to cover tax withholding obligation from settlement of vested restricted stock units. F2 · price: The price reported above reflects the weighted average price of the shares sold. The sale price ranged from $3.65 to $3.91 per share. Upon request from the SEC staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| November 18, 2024 Filed Nov 20, 2024 21:19 UTC |
Tachibana AaronCFO AND COO
|
SaleCommon Stock | 1,307 | $3.79 | $4,953.53 |
DisclosureSEC source: 0001415889-24-027347 · form4-11202024_091113.xml · nonDerivative · entry 1 Tachibana Aaron · CIK 0001401786 · CFO AND COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 173,963 F1 · shares: Shares automatically sold to cover tax withholding obligation from settlement of vested restricted stock units. F2 · price: The price reported above reflects the weighted average price of the shares sold. The sale price ranged from $3.76 to $3.79 per share. Upon request from the SEC staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| November 18, 2024 Filed Nov 20, 2024 21:14 UTC |
Chen RichardCHIEF MEDICAL OFFICER AND EVP
|
SaleCommon Stock | 921 | $3.79 | $3,490.59 |
DisclosureSEC source: 0001415889-24-027338 · form4-11202024_091153.xml · nonDerivative · entry 1 Chen Richard · CIK 0001779787 · CHIEF MEDICAL OFFICER AND EVP 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 128,720 F1 · shares: Shares automatically sold to cover tax withholding obligation from settlement of vested restricted stock units. F2 · price: The price reported above reflects the weighted average price of the shares sold. The sale price ranged from $3.76 to $3.79 per share. Upon request from the SEC staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. F3 · balance_after: Includes 2,414 shares acquired under the Issuer's Employee Stock Purchase Plan on October 31, 2024. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.